How To Put A Price Tag On Emerging Therapies
Source: Life Science Leader
By Herman Sanchez & Andrew Combs
There’s no doubt that partnerships and M&As are key growth drivers in the biopharma industry. But for collaborative relationships to occur, understanding the value of a company’s underlying assets is critical.
Forecast and valuation engagements in the life sciences industry have grown following recent venture investment trends. According to Evaluate, between 2012 and 2017, both total investments and average investments per financing event increased by about 20 percent each year.
VIEW THE MAGAZINE ARTICLE!
Log In
Signing up provides unlimited access to:
Free Sign Up

Signing up provides unlimited access to:
- Trend and Leadership Articles
- Case Studies
- Extensive Product Database
- Premium Content
HELLO. PLEASE LOG IN.
X
Not yet a member of Life Science Leader? Register today.
ACCOUNT SIGN UP
X
Please fill in your account details
ACCOUNT SIGN UP
This website uses cookies to ensure you get the best experience on our website. Learn more